NasdaqGM:CDNABiotechs
Does CareDx’s Profit Jump And Higher 2026 Outlook Change The Bull Case For CDNA?
In late July 2026, CareDx, Inc. reported second-quarter revenue of US$131.95 million and net income of US$110.64 million, a shift from a loss a year earlier, and raised its full-year 2026 revenue outlook to US$490–500 million.
The company paired its earnings strength with capital moves, completing a US$50.00 million buyback program while also filing an US$80.30 million shelf registration for 2,267,800 ESOP-related common shares, highlighting active balance sheet and employee ownership...